Table of Contents
1. Methodology and Scope
1.1. Methodology
1.1.1. Initial data exploration
1.1.2. Statistical model and forecast
1.1.3. Industry insights and validation
1.1.4. Definitions forecast parameters
1.2. Data sources
1.2.1. Secondary
1.2.2. Primary
2 Market Overview
2.1 Disease Risk and Health Test Introduction
2.2 Market Analysis by Type
2.2.1 Celiac Disease
2.2.2 Parkinson Disease
2.2.3 Alzheimer Disease
2.2.4 Others
2.3 Market Analysis by Applications
2.3.1 Online
2.3.2 Offline
2.4 Market Analysis by Regions
2.4.1 Europe (Germany, France, UK, Italy, Russia and Turkey)
2.4.1.1 Germany Market States and Outlook (2013-2026)
2.4.1.2 France Market States and Outlook (2013-2026)
2.4.1.3 UK Market States and Outlook (2013-2026)
2.4.1.4 Italy Market States and Outlook (2013-2026)
2.4.1.5 Russia Market States and Outlook (2013-2026)
2.4.1.6 Turkey Market States and Outlook (2013-2026)
2.4.2 Middle East (Saudi Arabia, Israel, UAE and Iran)
2.4.2.1 Saudi Arabia Market States and Outlook (2013-2026)
2.4.2.2 UAE Market States and Outlook (2013-2026)
2.4.2.3 Israel Market States and Outlook (2013-2026)
2.4.2.4 Iran Market States and Outlook (2013-2026)
2.4.3 Africa (South Africa, Nigeria, Egypt and Algeria)
2.4.3.1 South Africa Market States and Outlook (2013-2026)
2.4.3.2 Nigeria Market States and Outlook (2013-2026)
2.4.3.3 Egypt Market States and Outlook (2013-2026)
2.4.3.4 Algeria Market States and Outlook (2013-2026)
2.5 Market Dynamics
2.5.1 Market Opportunities
2.5.2 Market Risk
2.5.3 Market Driving Force
2.6 Market Competition News and Trend
2.6.1 Merger, Consolidation or Acquisition News
2.6.2 Investment or Disinvestment News
2.6.3 New Product Development and Launch
3 EMEA Disease Risk and Health Test Market Competition, by Manufacturer
3.1 EMEA Disease Risk and Health Test Sales and Market Share by Manufacturer (2016-2018)
3.1.1 EMEA Disease Risk and Health Test Sales by Manufacturer (2016-2018)
3.1.2 EMEA Disease Risk and Health Test Sales Market Share by Manufacturer (2016-2018)
3.2 EMEA Disease Risk and Health Test Revenue and Market Share by Manufacturer (2016-2018)
3.2.1 EMEA Disease Risk and Health Test Revenue by Manufacturer (2016-2018)
3.2.2 EMEA Disease Risk and Health Test Revenue Market Share by Manufacturer (2016-2018)
3.3 EMEA Disease Risk and Health Test Price by Manufacturer (2016-2018)
3.4 Market Concentration Rate
3.4.1 Top 3 Disease Risk and Health Test Manufacturer Market Share (2016-2018)
3.4.2 Top 5 Disease Risk and Health Test Manufacturer Market Share (2016-2018)
3.5 Market Competition Trend
4 Manufacturers Profiles
4.1 24andMe
4.1.1 Business Overview
4.1.2 Disease Risk and Health Test Type and Applications
4.1.2.1 Product A
4.1.2.2 Product B
4.1.3 24andMe Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.2 MyHeritage
4.2.1 Business Overview
4.2.2 Disease Risk and Health Test Type and Applications
4.2.2.1 Product A
4.2.2.2 Product B
4.2.3 MyHeritage Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.3 LabCorp
4.3.1 Business Overview
4.3.2 Disease Risk and Health Test Type and Applications
4.3.2.1 Product A
4.3.2.2 Product B
4.3.3 LabCorp Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.4 Myriad Genetics
4.4.1 Business Overview
4.4.2 Disease Risk and Health Test Type and Applications
4.4.2.1 Product A
4.4.2.2 Product B
4.4.3 Myriad Genetics Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.5 Ancestry.com
4.5.1 Business Overview
4.5.2 Disease Risk and Health Test Type and Applications
4.5.2.1 Product A
4.5.2.2 Product B
4.5.3 Ancestry.com Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.6 Quest Diagnostics
4.6.1 Business Overview
4.6.2 Disease Risk and Health Test Type and Applications
4.6.2.1 Product A
4.6.2.2 Product B
4.6.3 Quest Diagnostics Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.7 Gene By Gene
4.7.1 Business Overview
4.7.2 Disease Risk and Health Test Type and Applications
4.7.2.1 Product A
4.7.2.2 Product B
4.7.3 Gene By Gene Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.8 DNA Diagnostics Center
4.8.1 Business Overview
4.8.2 Disease Risk and Health Test Type and Applications
4.8.2.1 Product A
4.8.2.2 Product B
4.8.3 DNA Diagnostics Center Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.9 Invitae
4.9.1 Business Overview
4.9.2 Disease Risk and Health Test Type and Applications
4.9.2.1 Product A
4.9.2.2 Product B
4.9.3 Invitae Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.10 IntelliGenetics
4.10.1 Business Overview
4.10.2 Disease Risk and Health Test Type and Applications
4.10.2.1 Product A
4.10.2.2 Product B
4.10.3 IntelliGenetics Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.11 Ambry Genetics
4.11.1 Business Overview
4.11.2 Disease Risk and Health Test Type and Applications
4.11.2.1 Product A
4.11.2.2 Product B
4.11.3 Ambry Genetics Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.12 Living DNA
4.12.1 Business Overview
4.12.2 Disease Risk and Health Test Type and Applications
4.12.2.1 Product A
4.12.2.2 Product B
4.12.3 Living DNA Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.13 EasyDNA
4.13.1 Business Overview
4.13.2 Disease Risk and Health Test Type and Applications
4.13.2.1 Product A
4.13.2.2 Product B
4.13.3 EasyDNA Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.14 Pathway Genomics
4.14.1 Business Overview
4.14.2 Disease Risk and Health Test Type and Applications
4.14.2.1 Product A
4.14.2.2 Product B
4.14.3 Pathway Genomics Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.15 Centrillion Technology
4.15.1 Business Overview
4.15.2 Disease Risk and Health Test Type and Applications
4.15.2.1 Product A
4.15.2.2 Product B
4.15.3 Centrillion Technology Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.16 Xcode
4.16.1 Business Overview
4.16.2 Disease Risk and Health Test Type and Applications
4.16.2.1 Product A
4.16.2.2 Product B
4.16.3 Xcode Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.17 Color Genomics
4.17.1 Business Overview
4.17.2 Disease Risk and Health Test Type and Applications
4.17.2.1 Product A
4.17.2.2 Product B
4.17.3 Color Genomics Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.18 Anglia DNA Services
4.18.1 Business Overview
4.18.2 Disease Risk and Health Test Type and Applications
4.18.2.1 Product A
4.18.2.2 Product B
4.18.3 Anglia DNA Services Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.19 African Ancestry
4.19.1 Business Overview
4.19.2 Disease Risk and Health Test Type and Applications
4.19.2.1 Product A
4.19.2.2 Product B
4.19.3 African Ancestry Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.20 Canadian DNA Services
4.20.1 Business Overview
4.20.2 Disease Risk and Health Test Type and Applications
4.20.2.1 Product A
4.20.2.2 Product B
4.20.3 Canadian DNA Services Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.21 DNA Family Check
4.21.1 Business Overview
4.21.2 Disease Risk and Health Test Type and Applications
4.21.2.1 Product A
4.21.2.2 Product B
4.21.3 DNA Family Check Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.22 Alpha Biolaboratories
4.22.1 Business Overview
4.22.2 Disease Risk and Health Test Type and Applications
4.22.2.1 Product A
4.22.2.2 Product B
4.22.3 Alpha Biolaboratories Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.23 Test Me DNA
4.23.1 Business Overview
4.23.2 Disease Risk and Health Test Type and Applications
4.23.2.1 Product A
4.23.2.2 Product B
4.23.3 Test Me DNA Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.24 24 Mofang
4.24.1 Business Overview
4.24.2 Disease Risk and Health Test Type and Applications
4.24.2.1 Product A
4.24.2.2 Product B
4.24.3 24 Mofang Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.25 Genetic Health
4.25.1 Business Overview
4.25.2 Disease Risk and Health Test Type and Applications
4.25.2.1 Product A
4.25.2.2 Product B
4.25.3 Genetic Health Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.26 DNA Services of America
4.26.1 Business Overview
4.26.2 Disease Risk and Health Test Type and Applications
4.26.2.1 Product A
4.26.2.2 Product B
4.26.3 DNA Services of America Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.27 Shuwen Health Sciences
4.27.1 Business Overview
4.27.2 Disease Risk and Health Test Type and Applications
4.27.2.1 Product A
4.27.2.2 Product B
4.27.3 Shuwen Health Sciences Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.28 Mapmygenome
4.28.1 Business Overview
4.28.2 Disease Risk and Health Test Type and Applications
4.28.2.1 Product A
4.28.2.2 Product B
4.28.3 Mapmygenome Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.29 Full Genomes
4.29.1 Business Overview
4.29.2 Disease Risk and Health Test Type and Applications
4.29.2.1 Product A
4.29.2.2 Product B
4.29.3 Full Genomes Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
5 EMEA Disease Risk and Health Test Market Analysis by Regions
5.1 EMEA Disease Risk and Health Test Sales, Revenue and Market Share by Regions
5.1.1 EMEA Disease Risk and Health Test Sales by Regions (2013-2018)
5.1.2 EMEA Disease Risk and Health Test Revenue by Regions (2013-2018)
5.2 Europe Disease Risk and Health Test Sales and Growth Rate (2013-2018)
5.3 Middle East Disease Risk and Health Test Sales and Growth Rate (2013-2018)
5.4 Africa Disease Risk and Health Test Sales and Growth Rate (2013-2018)
6 Europe Disease Risk and Health Test by Countries, Type, Application and Manufacturers
6.1 Europe Disease Risk and Health Test Sales, Revenue and Market Share by Countries
6.1.1 Europe Disease Risk and Health Test Sales by Countries (2013-2018)
6.1.2 Europe Disease Risk and Health Test Revenue by Countries (2013-2018)
6.1.3 Germany Disease Risk and Health Test Sales and Growth Rate (2013-2018)
6.1.4 France Disease Risk and Health Test Sales and Growth Rate (2013-2018)
6.1.5 UK Disease Risk and Health Test Sales and Growth Rate (2013-2018)
6.1.6 Russia Disease Risk and Health Test Sales and Growth Rate (2013-2018)
6.1.7 Italy Disease Risk and Health Test Sales and Growth Rate (2013-2018)
6.1.8 Turkey Disease Risk and Health Test Sales and Growth Rate (2013-2018)
6.2 Europe Disease Risk and Health Test Sales and Revenue (value) by Manufacturers (2016-2018)
6.2.1 Europe Disease Risk and Health Test Sales by Manufacturers (2016-2018)
6.2.2 Europe Disease Risk and Health Test Revenue by Manufacturers (2016-2018)
6.3 Europe Disease Risk and Health Test Sales and Sales Share by Type (2013-2018)
6.3.1 Europe Disease Risk and Health Test Sales by Type (2013-2018)
6.3.2 Europe Disease Risk and Health Test Sales Share by Type (2013-2018)
6.4 Europe Disease Risk and Health Test Sales and Sales Share by Application (2013-2018)
6.4.1 Europe Disease Risk and Health Test Sales by Application (2013-2018)
6.4.2 Europe Disease Risk and Health Test Sales Share by Application (2013-2018)
7 Middle East Disease Risk and Health Test by Countries, Type, Application and Manufacturers
7.1 Middle East Disease Risk and Health Test Sales, Revenue and Market Share by Countries
7.1.1 Middle East Disease Risk and Health Test Sales by Countries (2013-2018)
7.1.2 Middle East Disease Risk and Health Test Revenue by Countries (2013-2018)
7.1.3 Saudi Arabia Disease Risk and Health Test Sales and Growth Rate (2013-2018)
7.1.4 Israel Disease Risk and Health Test Sales and Growth Rate (2013-2018)
7.1.5 UAE Disease Risk and Health Test Sales and Growth Rate (2013-2018)
7.1.6 Iran Disease Risk and Health Test Sales and Growth Rate (2013-2018)
7.2 Middle East Disease Risk and Health Test Sales and Revenue (value) by Manufacturers (2016-2018)
7.2.1 Middle East Disease Risk and Health Test Sales by Manufacturers (2016-2018)
7.2.2 Middle East Disease Risk and Health Test Revenue by Manufacturers (2016-2018)
7.3 Middle East Disease Risk and Health Test Sales and Sales Share by Type (2013-2018)
7.2.1 Middle East Disease Risk and Health Test Sales by Type (2013-2018)
7.2.2 Middle East Disease Risk and Health Test Sales Share by Type (2013-2018)
7.4 Middle East Disease Risk and Health Test Sales and Sales Share by Application (2013-2018)
7.4.1 Middle East Disease Risk and Health Test Sales by Application (2013-2018)
7.4.2 Middle East Disease Risk and Health Test Sales Share by Application (2013-2018)
8 Africa Disease Risk and Health Test by Countries, Type, Application and Manufacturers
8.1 Africa Disease Risk and Health Test Sales, Revenue and Market Share by Countries
8.1.1 Africa Disease Risk and Health Test Sales by Countries (2013-2018)
8.1.2 Africa Disease Risk and Health Test Revenue by Countries (2013-2018)
8.1.3 South Africa Disease Risk and Health Test Sales and Growth Rate (2013-2018)
8.1.4 Nigeria Disease Risk and Health Test Sales and Growth Rate (2013-2018)
8.1.5 Egypt Disease Risk and Health Test Sales and Growth Rate (2013-2018)
8.1.6 Algeria Disease Risk and Health Test Sales and Growth Rate (2013-2018)
8.2 Middle East Disease Risk and Health Test Sales and Revenue (value) by Manufacturers (2016-2018)
8.2.1 Middle East Disease Risk and Health Test Sales by Manufacturers (2016-2018)
8.2.2 Middle East Disease Risk and Health Test Revenue by Manufacturers (2016-2018)
8.3 Middle East Disease Risk and Health Test Sales and Sales Share by Type (2013-2018)
8.3.1 Middle East Disease Risk and Health Test Sales by Type (2013-2018)
8.3.2 Middle East Disease Risk and Health Test Sales Share by Type (2013-2018)
8.4 Middle East Disease Risk and Health Test Sales and Sales Share by Application (2013-2018)
8.4.1 Middle East Disease Risk and Health Test Sales by Application (2013-2018)
8.4.2 Middle East Disease Risk and Health Test Sales Share by Application (2013-2018)
9 EMEA Disease Risk and Health Test Market Segment by Type
9.1 EMEA Disease Risk and Health Test Sales, Revenue and Market Share by Type (2013-2018)
9.1.1 EMEA Disease Risk and Health Test Sales and Market Share by Type (2013-2018)
9.1.2 EMEA Disease Risk and Health Test Revenue and Market Share by Type (2013-2018)
9.2 EMEA Celiac Disease Sales Growth Rate and Price
9.2.1 EMEA Celiac Disease Sales Growth Rate (2013-2018)
9.2.2 EMEA Celiac Disease Price (2013-2018)
9.3 Parkinson Disease Sales Growth Rate and Price
9.3.1 EMEA Parkinson Disease Sales Growth Rate (2013-2018)
9.3.2 EMEA Parkinson Disease Price (2013-2018)
9.4 Alzheimer Disease Sales Growth Rate and Price
9.4.1 EMEA Alzheimer Disease Sales Growth Rate (2013-2018)
9.4.2 EMEA Alzheimer Disease Price (2013-2018)
9.5 Others Sales Growth Rate and Price
9.5.1 EMEA Others Sales Growth Rate (2013-2018)
9.5.2 EMEA Others Price (2013-2018)
10 EMEA Disease Risk and Health Test Market Segment by Application
10.1 EMEA Disease Risk and Health Test Sales Market Share by Application (2013-2018)
10.2 Online Sales Growth Rate (2013-2018)
10.3 Offline Sales Growth Rate (2013-2018)
11 EMEA Disease Risk and Health Test Market Forecast (2019-2026)
11.1 EMEA Disease Risk and Health Test Sales, Revenue and Growth Rate (2019-2026)
11.2 Disease Risk and Health Test Market Forecast by Regions (2019-2026)
11.2.1 Europe Disease Risk and Health Test Market Forecast by Regions (2019-2026)
11.2.1.1 Germany Disease Risk and Health Test Sales Forecast 2019-2026
11.2.1.2 France Disease Risk and Health Test Sales Forecast 2019-2026
11.2.1.3 UK Disease Risk and Health Test Sales Forecast 2019-2026
11.2.1.4 Russia Disease Risk and Health Test Sales Forecast 2019-2026
11.2.1.5 Italy Disease Risk and Health Test Sales Forecast 2019-2026
11.2.1.6 Turkey Disease Risk and Health Test Sales Forecast 2019-2026
11.2.2 Middle East Market Forecast by Regions (2019-2026)
11.2.2.1 Saudi Arabia Disease Risk and Health Test Sales Forecast 2019-2026
11.2.2.2 Israel Disease Risk and Health Test Sales Forecast 2019-2026
11.2.2.3 UAE Disease Risk and Health Test Sales Forecast 2019-2026
11.2.2.4 Iran Disease Risk and Health Test Sales Forecast 2019-2026
11.2.3 Africa Market Forecast by Regions (2019-2026)
11.2.3.1 South Africa Disease Risk and Health Test Sales Forecast 2019-2026
11.2.3.2 Nigeria Disease Risk and Health Test Sales Forecast 2019-2026
11.2.3.3 Egypt Disease Risk and Health Test Sales Forecast 2019-2026
11.2.3.4 Algeria Disease Risk and Health Test Sales Forecast 2019-2026
11.3 Disease Risk and Health Test Market Forecast by Type (2019-2026)
11.3.1 EMEA Disease Risk and Health Test Sales Forecast by Type (2019-2026)
11.3.2 EMEA Disease Risk and Health Test Market Share Forecast by Type (2019-2026)
11.4 Disease Risk and Health Test Market Forecast by Application (2019-2026)
11.4.1 EMEA Disease Risk and Health Test Sales Forecast by Application (2019-2026)
11.4.2 EMEA Disease Risk and Health Test Market Share Forecast by Application (2019-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Future Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors, Traders and Dealers
12 Research Findings and Conclusion